Stephen Master
Division Chief and Director, Metabolic and Advanced Diagnostics · Children's Hospital of Philadelphia
Credentials: · · · ·
History
- Present
Metabolic and Advanced Diagnostics Division · Children's Hospital of Philadelphia
- 2009–2011
Research
Nature Genetics · 1996 · 470 citations
The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor
Genes & Development · 2003 · 282 citations
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
Kidney International · 2013 · 246 citations
11 papers
10 papers
8 papers
7 papers
6 papers
6 papers
6 papers
5 papers
Grants
- 2026–2028
Composite Interferon Signaling Response Biomarker in Aicardi Goutières Syndrome
National Institute of Neurological Disorders and Stroke · R61
PI · $707.3K · Children's Hosp of Philadelphia
- 2021–2025
Microsampling Assays for Immunosuppressive Drugs in Children
National Institute of Child Health and Human Development · R21
Contact PI · $218.4K · Children's Hosp of Philadelphia
- 2010–2013
DNA Methylation-Based Assays for Detecting Disease Spread in Rhabdomyosarcoma
National Cancer Institute · R21
Contact PI · $214.1K · University of Pennsylvania
Clinical trials
- 2011–2016
Principal investigator · Completed
Children's Oncology Group